Neumann PJ, Anderson JE, Panzer AD et al. Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures [version 2; referees: 3 approved]. Gates Open Res 2018, 2:5. [Gates Open Research]
Cohen JT, Neumann PJ, Wong JB. A Call for Open-Source Cost-Effectiveness Analysis. Annals of Internal Medicine. August 29, 2017. Epub ahead of print. [PubMed]
Neumann PJ, Thorat T, Zhong Y, Anderson JE, Farquhar M, Salem M, Sandberg E, Saret CJ, Wilkinson C, Cohen JT. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted. PLoS One. 2016; 11(12): e0168512. [PubMed]
Teerawattananon Y, Tantivess S, Yamabhai I, Tritasavit N, Walker DG, Cohen JT, Neumann PJ. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh. Health Research Policy and Systems, 2016. [PubMed]
Bilinski A, Neumann P, Cohen J, Thorat T, McDaniel K, Salomon JA (2017) When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs. PLoS Med 14 (10): e1002397. [PLOS Medicine]
Zhong Y, Thorat T, Cohen JT, Neumann PJ. A systematic review of studies reporting cost per disability-adjusted life year estimates. ISPOR 21st International Meeting; Washington DC. May 2016. Poster presentation.
Anderson JE, Thorat T, Neumann PJ, Cohen JT. Implementation status of cost-effective vaccines in GAVI-eligible countries. ISPOR 22nd International Meeting; Boston, MA. May 2017. Poster presentation.
Leech A, Kim D, Thorat T, Cohen JT, Neumann PJ. Cost-effectiveness thresholds in published cost-per-DALY studies. 12th World Congress of the International Health Economics Association (IHEA); Boston, MA. July 2017. Long oral presentation, special organized session.